You have 9 free searches left this month | to do more

venetoclax

Venetoclax is a drug used to treat Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and other conditions. Venetoclax is being actively studied in 234 studies and prior, has been studied in 25.

Top SponsorsTop SitesTop Investigators
AbbVieM D Anderson Cancer CenterMatthew S. Davids, MD
M.D. Anderson Cancer CenterMD Anderson Cancer CenterPaolo Ghia
Hoffmann-La RocheDana Farber Cancer InstituteAndrew Lane
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-10-27
Oct 27, 2021
U
Recruiting
  • AML
  • Aurora, Colorado
  • +1 more
2022-04-04
Apr 4, 2022
N
Recruiting
  • Chronic Lymphocytic Leukemia
  • Venetoclax
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-10-27
Oct 27, 2021
D
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-09-08
Sep 8, 2021
D
Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
2022-04-01
Apr 1, 2022
A
Available
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Venetoclax
  • (no location specified)
2022-03-28
Mar 28, 2022
M
Not yet recruiting
  • CLL
  • (no location specified)
2022-02-08
Feb 8, 2022
U
Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
2022-02-15
Feb 15, 2022
C
Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Venetoclax
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
2022-02-28
Feb 28, 2022
M
Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Venetoclax
  • +5 more
  • (no location specified)
2022-03-30
Mar 30, 2022
U
Recruiting
  • Chronic Lymphocytic Leukemia
  • San Diego, California
    UCSD Koman Family Outpatient Pavilion
2021-11-24
Nov 24, 2021
C
Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2022-02-08
Feb 8, 2022
L
Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
2022-03-04
Mar 4, 2022
P
Recruiting
  • Breast Neoplasm Female
  • Venetoclax
  • +2 more
  • Melbourne, Victoria, Australia
  • +2 more
2022-03-10
Mar 10, 2022
K
Terminated
  • Primary CNS Lymphoma
  • Stuttgart, Baden-Württemberg, Germany
    Klinikum Stuttgart
2022-01-18
Jan 18, 2022
K
Withdrawn
  • Chronic Lymphocytic Leukemia
  • Loss of Chromosome 17p
  • (no location specified)
2021-10-29
Oct 29, 2021
C
Suspended
  • Leukemia
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2021-12-29
Dec 29, 2021
J
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
2022-03-16
Mar 16, 2022
D
Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-11-02
Nov 2, 2021
U
Not yet recruiting
  • Myeloproliferative Neoplasm
  • BCR-ABL Negative
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-09-29
Sep 29, 2021
M
Withdrawn
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-23
Feb 23, 2022
D
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-09-08
Sep 8, 2021
M
Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2022-04-07
Apr 7, 2022
D
Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Venetoclax
  • +2 more
  • Boston, Massachusetts
  • +1 more
2021-10-19
Oct 19, 2021